Publication: A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B
Submitted Date
Received Date
Accepted Date
Issued Date
2001-12-01
Copyright Date
Announcement No.
Application No.
Patent No.
Valid Date
Resource Type
Edition
Resource Version
Language
File Type
No. of Pages/File Size
ISBN
ISSN
01634453
eISSN
Scopus ID
WOS ID
Pubmed ID
arXiv ID
Call No.
Other identifier(s)
2-s2.0-0035700466
Journal Title
Volume
Issue
item.page.oaire.edition
Start Page
End Page
Access Rights
Access Status
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Physical Location
Bibliographic Citation
Journal of Infection. Vol.43, No.4 (2001), 226-233
Citation
P. Pitisuttithum, S. Tansuphasawadikul, A. J.H. Simpson, P. A. Howe, N. J. White (2001). A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/26672.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B
Alternative Title(s)
Author's Affiliation
Author's E-mail
Editor(s)
Editor's Affiliation
Corresponding Author(s)
Creator(s)
Compiler
Advisor(s)
Illustrator(s)
Applicant(s)
Inventor(s)
Issuer
Assignee
Other Contributor(s)
Series
Has Part
Abstract
Objective: To assess kinetic of cryptococci in the cerebrospinal fluid (CSF) and outcome of AIDS-associated cyptococcal meningitis after high-dose amphotericin B. Patients and Methods: A prospective study involving Thai adults (n = 106) with cryptococcal meningitis associated with AIDS was conducted to determine the kinetic of cryptococci in CSF and prognostic factors affecting survival after high-dose amphotericin B (0.7 mg/kg/day) followed by oral azole treatment. Cerebrospinal fluids were collected for cryptococcal count and culture at weekly intervals for at least 2 weeks or until CSF cultures were negative for cryptococci. All patients were followed monthly for 1 year or until death in order to detect relapse or occurrence of any other opportunistic infection. Results: A total of 106 AIDS patients with cryptococcal meningitis were enrolled. The geometric mean (range) total and viable cryptococcal counts in CSF on admission were 430 000 (1000 to 3.4 × 107) and 31 000 (10 to 1.4 × 107) per ml, respectively. Both total and viable cryptococcal counts declined monoexponentially with an elimination half life of 4 days. The cumulative CSF yeast clearance rates were 38% and 56% at 2 and 4 weeks, respectively. Early death was associated significantly with previous history of weight loss [relative risk (RR) = 2.2; 95% CI, 1.2-3.9], Glasgow Coma Score <13 (RR = 2.33; 95% CI, 1.55-3.50), and hypoalbuminaemia (P < 0.001). Later mortality was associated delayed CSF yeast clearance (RR = 3.6; 95% CI, 1.9-6.4) and relapse (RR = 3.9; 95% CI, 1.4-10.8). Conclusion: High-dose amphotericin B was not as effective as previously thought. Cumulative mortality at 2 weeks, 4 weeks and 1 year were 16%, 24% and 76%, respectively. © 2001 The British Infection Society.